Frequent presence of incomplete HPV16 E7 ORFs in lung carcinomas: Memories of viral infection

Journal of Clinical Virology

Volumn 49, Issue 3, 2010, Pages 169-174

  Krikelis, D ^a   Tzimagiorgis, G ^a   Georgiou, E ^a   Destouni, C ^b   Agorastos, T ^a   Haitoglou, C ^a   Kouidou, S ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

Bronchial washings; Detection method; HPV16 E7; Lung carcinoma; PCR; PvuII digestion

Indexed keywords

PROTEIN E7;

ARTICLE; CANCER TISSUE; CONTROLLED STUDY; FALSE POSITIVE RESULT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; LUNG CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SEQUENCE ANALYSIS; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; VIRUS INFECTION;

CARCINOMA; HUMAN PAPILLOMAVIRUS 16; HUMANS; LUNG NEOPLASMS; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY, MOLECULAR; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 77957671240     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.07.020     Document Type: Article

References (69)

1. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 1995, 87(June (11)):796-802.
2. Syrjanen K., Syrjanen S. Papillomavirus infections in human pathology 2000, John Wiley and Sons, New York.
3. Syrjanen K.J. Condylomatous changes in neoplastic bronchial epithelium. Report of a case. Respiration 1979, 38(5):299-304.
4. Richart R.M., Masood S., Syrjanen K.J., Vassilakos P., Kaufman R.H., Meisels A., et al. Human papillomavirus. International Academy of Cytology Task Force summary. Diagnostic cytology towards the 21st century: an international expert conference and tutorial. Acta Cytol 1998, 42(January (1)):50-58.
5. Auerbach O., Garfinkel L., Parks V.R. Histologic type of lung cancer in relation to smoking habits, year of diagnosis and sites of metastases. Chest 1975, 67(April (4)):382-387.
6. Cheng Y.W., Chiou H.L., Sheu G.T., Hsieh L.L., Chen J.T., Chen C.Y., et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 2001, 61(April (7)):2799-2803.
7. Ciotti M., Giuliani L., Ambrogi V., Ronci C., Benedetto A., Mineo T.C., et al. Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer. Oncol Rep 2006, 16(July (1)):183-189.
8. Hirayasu T., Iwamasa T., Kamada Y., Koyanagi Y., Usuda H., Genka K. Human papillomavirus DNA in squamous cell carcinoma of the lung. J Clin Pathol 1996, 49(October (10)):810-817.
9. Jain N., Singh V., Hedau S., Kumar S., Daga M.K., Dewan R., et al. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 2005, 128(December (6)):3999-4007.
10. Miyagi J., Tsuhako K., Kinjo T., Iwamasa T., Hirayasu T. Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan. J Clin Pathol 2000, 53(September (9)):676-684.
11. Miyagi J., Kinjo T., Tsuhako K., Higa M., Iwamasa T., Kamada Y., et al. Extremely high Langerhans cell infiltration contributes to the favourable prognosis of HPV-infected squamous cell carcinoma and adenocarcinoma of the lung. Histopathology 2001, 38(April (4)):355-367.
12. Tsuhako K., Nakazato I., Hirayasu T., Sunakawa H., Iwamasa T. Human papillomavirus DNA in adenosquamous carcinoma of the lung. J Clin Pathol 1998, 51(October (10)):741-749.
13. Klein F., min Kotb W.F., Petersen I. Incidence of human papilloma virus in lung cancer. Lung Cancer 2009, 65(July (1)):13-18.
14. Georgiou E., Valeri R., Tzimagiorgis G., Anzel J., Krikelis D., Tsilikas C., et al. Aberrant p16 promoter methylation among Greek lung cancer patients and smokers: correlation with smoking. Eur J Cancer Prev 2007, 16(October (5)):396-402.
15. Husnjak K., Grce M., Magdic L., Pavelic K. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J Virol Methods 2000, 88(August (2)):125-134.
16. Soler C., Allibert P., Chardonnet Y., Cros P., Mandrand B., Thivolet J. Detection of human papillomavirus types 6, 11, 16 and 18 in mucosal and cutaneous lesions by the multiplex polymerase chain reaction. J Virol Methods 1991, 35(November (2)):143-157.
17. Bejui-Thivolet F., Liagre N., Chignol M.C., Chardonnet Y., Patricot L.M. Detection of human papillomavirus DNA in squamous bronchial metaplasia and squamous cell carcinomas of the lung by in situ hybridization using biotinylated probes in paraffin-embedded specimens. Hum Pathol 1990, 21(January (1)):111-116.
18. Bejui-Thivolet F., Chardonnet Y., Patricot L.M. Human papillomavirus type 11DNA in papillary squamous cell lung carcinoma. Virchows Arch A: Pathol Anat Histopathol 1990, 417(5):457-461.
19. Brouchet L., Valmary S., Dahan M., Didier A., Galateau-Salle F., Brousset P., et al. Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer 2005, 92(February (4)):743-746.
20. Fei Y., Yang J., Hsieh W.C., Wu J.Y., Wu T.C., Goan Y.G., et al. Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China. Jpn J Clin Oncol 2006, 36(May (5)):274-279.
21. Kaya H., Kotiloglu E., Inanli S., Ekicioglu G., Bozkurt S.U., Tutkun A., et al. Prevalence of human papillomavirus (HPV) DNA in larynx and lung carcinomas. Pathologica 2001, 93(October (5)):531-534.
22. Kulski J.K., Demeter T., Mutavdzic S., Sterrett G.F., Mitchell K.M., Pixley E.C. Survey of histologic specimens of human cancer for human papillomavirus types 6/11/16/18 by filter in situ hybridization. Am J Clin Pathol 1990, 94(November (5)):566-570.
23. Syrjanen K., Syrjanen S., Kellokoski J., Karja J., Mantyjarvi R. Human papillomavirus (HPV) type 6 and 16 DNA sequences in bronchial squamous cell carcinomas demonstrated by in situ DNA hybridization. Lung 1989, 167(1):33-42.
24. Syrjanen K.J., Syrjanen S.M. Human papillomavirus DNA in bronchial squamous cell carcinomas. Lancet 1987, 1(January (8525)):168-169.
25. Thomas P., De Lamballerie X., Garbe L., Castelnau O., Kleisbauer J.P. Detection of human papillomavirus by polymerase chain reaction in primary lung carcinoma. Bull Cancer 1996, 83(October (10)):842-846.
26. Yousem S.A., Ohori N.P., Sonmez-Alpan E. Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer 1992, 69(February (3)):693-697.
27. al-Ghamdi A.A., Sanders C.M., Keefe M., Coggon D., Maitland N.J. Human papillomavirus DNA and TP53 mutations in lung cancers from butchers. Br J Cancer 1995, 72(August (2)):293-297.
28. Aguayo F., Castillo A., Koriyama C., Higashi M., Itoh T., Capetillo M., et al. Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile. Br J Cancer 2007, 97(July (1)):85-91.
29. Cheng Y.W., Wu M.F., Wang J., Yeh K.T., Goan Y.G., Chiou H.L., et al. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res 2007, 67(November (22)):10686-10693.
30. Chiou H.L., Wu M.F., Liaw Y.C., Cheng Y.W., Wong R.H., Chen C.Y., et al. The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer 2003, 97(March (6)):1558-1563.
31. Coissard C.J., Besson G., Polette M.C., Monteau M., Birembaut P.L., Clavel C.E. Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases. Mod Pathol 2005, 18(December (12)):1606-1609.
32. Da J., Chen L., Hu Y. Human papillomavirus infection and p53 gene mutation in primary lung cancer. Zhonghua Zhong Liu Za Zhi 1996, 18(January (1)):27-29.
33. Giuliani L., Jaxmar T., Casadio C., Gariglio M., Manna A., D'Antonio D., et al. Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer 2007, 57(September (3)):273-281.
34. Gorgoulis V.G., Zacharatos P., Kotsinas A., Kyroudi A., Rassidakis A.N., Ikonomopoulos J.A., et al. Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 1999, 30(March (3)):274-283.
35. Hennig E.M., Suo Z., Karlsen F., Holm R., Thoresen S., Nesland J.M. HPV positive bronchopulmonary carcinomas in women with previous high-grade cervical intraepithelial neoplasia (CIN III). Acta Oncol 1999, 38(5):639-647.
36. Hennig E.M., Di L.A., Venuti A., Holm R., Marcante M.L., Nesland J.M. HPV 16 in multiple neoplastic lesions in women with CIN III. J Exp Clin Cancer Res 1999, 18(September (3)):369-377.
37. Hiroshima K., Toyozaki T., Iyoda A., Ohwada H., Kado S., Shirasawa H., et al. Ultrastructural study of intranuclear inclusion bodies of pulmonary adenocarcinoma. Ultrastruct Pathol 1999, 23(November (6)):383-389.
38. Hu K., Li Q., Yang J., Hu S. Detection of human papillomavirus types 16, 18 DNA related sequences in bronchogenic carcinoma. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 1997, 11(June (2)):147-149.
39. Iwamasa T., Miyagi J., Tsuhako K., Kinjo T., Kamada Y., Hirayasu T., et al. Prognostic implication of human papillomavirus infection in squamous cell carcinoma of the lung. Pathol Res Pract 2000, 196(4):209-218.
40. Li Q., Hu K., Pan X., Cao Z., Yang J., Hu S. Detection of human papillomavirus types 16, 18 DNA related sequences in bronchogenic carcinoma by polymerase chain reaction. Chin Med J (Engl) 1995, 108(August (8)):610-614.
41. Lin T.S., Lee H., Chen R.A., Ho M.L., Lin C.Y., Chen Y.H., et al. An association of DNMT3b protein expression with P16INK4a promoter hypermethylation in non-smoking female lung cancer with human papillomavirus infection. Cancer Lett 2005, 226(August (1)):77-84.
42. Liu H.R., Xing L.Q., Si J.Y. [A study of human papillary virus infection by in situ hybridization and histopathology in squamous cell carcinoma of the lung]. Zhonghua Bing Li Xue Za Zhi 1994, 23(October (5)):299-301.
43. Miasko A., Niklinska W., Niklinski J., Chyczewska E., Naumnik W., Chyczewski L. Detection of human papillomavirus in non-small cell lung carcinoma by polymerase chain reaction. Folia Histochem Cytobiol 2001, 39(2):127-128.
44. Nadji S.A., Mokhtari-Azad T., Mahmoodi M., Yahyapour Y., Naghshvar F., Torabizadeh J., et al. Relationship between lung cancer and human papillomavirus in north of Iran, Mazandaran province. Cancer Lett 2007, 248(April (1)):41-46.
45. Nuorva K., Soini Y., Kamel D., Pollanen R., Bloigu R., Vahakangas K., et al. p53 protein accumulation and the presence of human papillomavirus DNA in bronchiolo-alveolar carcinoma correlate with poor prognosis. Int J Cancer 1995, 64(December (6)):424-429.
46. Papadakis E.D., Soulitzis N., Spandidos D.A. Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes. Br J Cancer 2002, 87(October (9)):1013-1018.
47. Park M.S., Chang Y.S., Shin J.H., Kim D.J., Chung K.Y., Shin D.H., et al. The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients. Yonsei Med J 2007, 48(February (1)):69-77.
48. Sagawa M., Saito Y., Endo C., Sato M., Usuda K., Kanma K., et al. [Detection of human papillomavirus type 16, 18 and 33 DNA in stage I (pT1N0M0) squamous cell carcinoma of the lung by polymerase chain reaction]. Kyobu Geka 1995, 48(May (5)):360-362.
49. Shamanin V., Delius H., de Villiers E.M. Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J Gen Virol 1994, 75(May (Pt 5)):1149-1156.
50. Shimizu E., Coxon A., Otterson G.A., Steinberg S.M., Kratzke R.A., Kim Y.W., et al. RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Oncogene 1994, 9(September (9)):2441-2448.
51. Soini Y., Nuorva K., Kamel D., Pollanen R., Vahakangas K., Lehto V.P., et al. Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma. Thorax 1996, 51(September (9)):887-893.
52. Szabo I., Sepp R., Nakamoto K., Maeda M., Sakamoto H., Uda H. Human papillomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction. Cancer 1994, 73(June (11)):2740-2744.
53. Thomas P., De Lamballerie X., Garbe L., Douagui H., Kleisbauer J.P. Detection of human papillomavirus DNA in primary lung carcinoma by nested polymerase chain reaction. Cell Mol Biol (Noisy-le-grand) 1995, 41(December (8)):1093-1097.
54. Wang J., Cheng Y.W., Wu D.W., Chen J.T., Chen C.Y., Chou M.C., et al. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan. Cancer Lett 2006, 235(April (1)):18-25.
55. Welt A., Hummel M., Niedobitek G., Stein H. Human papillomavirus infection is not associated with bronchial carcinoma: evaluation by in situ hybridization and the polymerase chain reaction. J Pathol 1997, 181(March (3)):276-280.
56. Xing L.Q., Liu H.R., Si J.Y. Analysis of the characteristics of human papilloma virus infection in 85 neoplasms of the respiratory system in adult patients. Zhonghua Zhong Liu Za Zhi 1994, 16(November (6)):424-427.
57. Zafer E., Ergun M.A., Alver G., Sahin F.I., Yavuzer S., Ekmekci A. Detection and typing of human papillomavirus in non-small cell lung cancer. Respiration 2004, 71(January (1)):88-90.
58. Zhang X., Zhu Y., Li L. Point mutation of p53 and detection of human papillomavirus DNA in bronchogenic carcinoma. Zhonghua Nei Ke Za Zhi 1995, 34(October (10)):673-675.
59. Bohlmeyer T., Le T.N., Shroyer A.L., Markham N., Shroyer K.R. Detection of human papillomavirus in squamous cell carcinomas of the lung by polymerase chain reaction. Am J Respir Cell Mol Biol 1998, 18(February (2)):265-269.
60. Castillo A., Aguayo F., Koriyama C., Shuyama K., Akiba S., Herrera-Goepfert R., et al. Human papillomavirus in lung carcinomas among three Latin American countries. Oncol Rep 2006, 15(April (4)):883-888.
61. Kinoshita I., aka-Akita H., Shindoh M., Fujino M., Akie K., Kato M., et al. Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung. Br J Cancer 1995, 71(February (2)):344-349.
62. Ogura H., Watanabe S., Fukushima K., Masuda Y., Fujiwara T., Yabe Y. Human papillomavirus DNA in squamous cell carcinomas of the respiratory and upper digestive tracts. Jpn J Clin Oncol 1993, 23(August (4)):221-225.
63. Papadopoulou K., Labropoulou V., Davaris P., Mavromara P., Tsimara-Papastamatiou H. Detection of human papillomaviruses in squamous cell carcinomas of the lung. Virchows Arch 1998, 433(July (1)):49-54.
64. Stremlau A., Gissmann L., Ikenberg H., Stark M., Bannasch P., zur Hausen H. Human papillomavirus type 16 related DNA in an anaplastic carcinoma of the lung. Cancer 1985, 55(April (8)):1737-1740.
65. Choo K.B., Pan C.C., Han S.H. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 1987, 161(November (1)):259-261.
66. Kalantari M., Lee D., Calleja-Macias I.E., Lambert P.F., Bernard H.U. Effects of cellular differentiation, chromosomal integration and 5-aza-2′-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology 2008, 374(May (2)):292-303.
67. Kouidou S., Agidou T., Kyrkou A., Andreou A., Katopodi T., Georgiou E., et al. Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma. Lung Cancer 2005, 50(December (3)):299-307.
68. Thorland E.C., Myers S.L., Gostout B.S., Smith D.I. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 2003, 22(February (8)):1225-1237.
69. Wentzensen N., Vinokurova S., von Knebel D.M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 2004, 64(June (11)):3878-3884.